PCSK9-binding antibody

· Amgen

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PCSK9-binding antibody, covering 2018-01-16 to 2018-01-16. Get the full timeline:

Most recent: Clinical Trial Update: Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects [Phase 3]